JPWO2019234240A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019234240A5
JPWO2019234240A5 JP2020568390A JP2020568390A JPWO2019234240A5 JP WO2019234240 A5 JPWO2019234240 A5 JP WO2019234240A5 JP 2020568390 A JP2020568390 A JP 2020568390A JP 2020568390 A JP2020568390 A JP 2020568390A JP WO2019234240 A5 JPWO2019234240 A5 JP WO2019234240A5
Authority
JP
Japan
Prior art keywords
hours
pharmaceutical composition
days
composition according
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020568390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525787A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/065016 external-priority patent/WO2019234240A1/en
Publication of JP2021525787A publication Critical patent/JP2021525787A/ja
Publication of JPWO2019234240A5 publication Critical patent/JPWO2019234240A5/ja
Pending legal-status Critical Current

Links

JP2020568390A 2018-06-07 2019-06-07 β−ラクタム化合物とプロベネシドの組み合わせとその使用 Pending JP2021525787A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862682116P 2018-06-07 2018-06-07
US62/682,116 2018-06-07
US201962804970P 2019-02-13 2019-02-13
US62/804,970 2019-02-13
PCT/EP2019/065016 WO2019234240A1 (en) 2018-06-07 2019-06-07 Combinations of beta-lactam compounds and probenecid and uses thereof

Publications (2)

Publication Number Publication Date
JP2021525787A JP2021525787A (ja) 2021-09-27
JPWO2019234240A5 true JPWO2019234240A5 (zh) 2022-06-15

Family

ID=67105981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020568390A Pending JP2021525787A (ja) 2018-06-07 2019-06-07 β−ラクタム化合物とプロベネシドの組み合わせとその使用

Country Status (8)

Country Link
US (2) US11554112B2 (zh)
EP (1) EP3801486A1 (zh)
JP (1) JP2021525787A (zh)
CN (1) CN112739338A (zh)
AU (1) AU2019281018A1 (zh)
BR (1) BR112020024498A2 (zh)
TW (1) TW202005970A (zh)
WO (1) WO2019234240A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021009755A (es) 2019-02-13 2021-11-17 Iterum Therapeutics International Ltd Combinaciones de compuestos beta-lactámicos y probenecid, y usos de los mismos.
KR20220152261A (ko) * 2020-03-11 2022-11-15 이테룸 테라퓨틱스 인터내셔널 리미티드 베타-락탐 화합물, 프로베네시드 및 발프로산의 조합물 및 그의 용도
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CA3173187A1 (en) * 2020-04-10 2021-10-14 Ralph A. Tripp Methods for treatment of coronavirus infections
CN111821462A (zh) * 2020-08-07 2020-10-27 安徽康正康仁药业有限公司 青霉素类钠盐与丙磺舒钠组成的复方冻干制剂
CN112076161B (zh) * 2020-08-07 2022-10-18 安徽康正康仁药业有限公司 一种头孢菌素类钠盐与丙磺舒钠组成的复方冻干制剂
CN111840236B (zh) * 2020-08-07 2022-09-02 安徽康正康仁药业有限公司 一种注射用美罗培南丙磺舒钠复方冻干制剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58128387A (ja) * 1982-01-26 1983-07-30 レオ・フア−マシユ−テイカル・プロダクツ・リミテツド・エイ/エス(レ−ベンス・ケミスケ・フアブリツク・プロデユクチオンスアクチ−セルスカブ) 新規β−ラクタム化合物およびその製法と用途
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
UA59394C2 (uk) 1998-03-27 2003-09-15 Каділа Фармацевтікелс (І.Ей) Лтд. Стійка у фіксованих дозах оральна фармацевтична композиція, що містить антибактеріальний засіб і мікроорганізм одночасно, та спосіб її одержання (варіанти)
WO2002036126A1 (en) 2000-10-30 2002-05-10 Lupin Limited Rapidly disintegrating sustained release cefuroxime axetil composition
AU2001227030A1 (en) 2000-11-22 2002-06-03 Lupin Laboratories Limited Pharmaceutical composition for controlled release of an active ingredient
ATE319434T1 (de) 2001-11-19 2006-03-15 Lupin Ltd Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam- antibiotikums
CN1853724A (zh) 2004-12-01 2006-11-01 吴晓辉 丙磺舒钠、钾与β-内酰胺类抗生素组成复方针剂及其用途
CN1813700A (zh) 2006-03-01 2006-08-09 吴晓辉 丙磺舒钠与青霉素类抗生素组成复方针剂
PE20080940A1 (es) 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
ES2355950T3 (es) * 2006-06-28 2011-04-01 Pfizer Products Inc. Profármacos de penem.
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
JP2016512817A (ja) 2013-03-15 2016-05-09 ヤンセン ファーマシューティカ エヌ.ベー. 高尿酸血症の治療におけるカナグリフロジンとプロベネシドの組合せ
TR201605632A1 (tr) 2016-04-28 2017-11-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profen ve tramadolün yavaş salinimli kombi̇nasyonlari
MX2021009755A (es) 2019-02-13 2021-11-17 Iterum Therapeutics International Ltd Combinaciones de compuestos beta-lactámicos y probenecid, y usos de los mismos.

Similar Documents

Publication Publication Date Title
RU2080116C1 (ru) Средство для лечения болей или воспалений
JP2002537252A (ja) 心血管事象を予防するための必須脂肪酸
JPH11506421A (ja) 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用
JP2019515884A5 (zh)
JPH03181422A (ja) 炎症の治療方法及び炎症の治療用合成薬
JP2008526953A (ja) 炎症性疾患のプラジカンテルでの治療
IL294736A (en) Preparations including 15-hydroxy-eicosapentaenoic acid and methods of using them
AU2007341218B2 (en) Isosorbide mononitrate derivatives for the treatment of intestinal disorders
JP2014505017A5 (zh)
RU2003100507A (ru) Фармацевтические композиции
JPWO2019234240A5 (zh)
US10363235B2 (en) Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same
JP2019531286A5 (zh)
JPWO2021168403A5 (zh)
HU222888B1 (hu) Anilid vegyületek alkalmazása I típusú allergiás betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
US20170319519A1 (en) Combination for the treatment of conditions involving muscular pain
JPS61176524A (ja) 抗炎症組成物
CN102659570A (zh) 二氟非诺贝特酸及其在药学上可接受的盐,以及它们的制备方法和应用
WO2011153247A1 (en) Combination therapies
US20200022936A1 (en) Combinations of diclofenac, h2 receptor antagonists and alkali metal bicarbonates for the treatment of pain and inflammation
JP2022528481A (ja) ピモジドとメトトレキサートの医薬組成物、及びその使用
JP2009507850A5 (zh)
JP2005509663A5 (zh)
US20080145409A1 (en) Composition for the treatment and prevention of peptic ulcer
CN115607545B (zh) 依达拉奉在自闭症谱系障碍治疗中的应用